Because the loss of the SUMOylation pathway is known to impair cell cycle progression at the G1 stage and cancer proliferation by targeting other cell cycle regulators (68, 69), the SUMO1/PSME3/20S proteasome axis–dependent protein degradation system is expected to be broadly involved in the regulation of cell cycle progression. Here, PSME3 is linked to cancer.